(Q35106465)

6 August 2017

1 reference

title

Digoxin remains useful in the management of chronic heart failure (English)

1 reference

6 August 2017

0 references

chronic heart failure

1 reference

G. William Dec

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12693728

23 December 2023

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=12693728

23 December 2023

publication date

1 March 2003

1 reference

full work available at URL

6 August 2017

https://api.elsevier.com/content/article/PII:S0025712502001724?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(02)00172-4

https://api.elsevier.com/content/article/PII:S0025712502001724?httpAccept=text/plain

23 December 2023

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(02)00172-4

Medical Clinics of North America

23 December 2023

published in

1 reference

6 August 2017

volume

87

1 reference

6 August 2017

issue

2

1 reference

6 August 2017

page(s)

317-337

1 reference

Molecular cloning of three distinct forms of the Na+,K+-ATPase alpha-subunit from rat brain

6 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900172-4

Influence of isoproterenol and ouabain on excitation-contraction coupling, cross-bridge function, and energetics in failing human myocardium

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900172-4

Digitalis. Mechanisms of action and clinical use.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900172-4

Quantitative relation of twitch and tonic tensions to intracellular Na+ activity in cardiac Purkinje fibers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900172-4

Enhancement of calcium current during digitalis inotrophy in mammalian heart: positive feed-back regulation by intracellular calcium?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900172-4

The role of the sodium pump in the effects of potassium-depleted solutions on mammalian cardiac muscle

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900172-4

Digoxin activates sarcoplasmic reticulum Ca(2+)-release channels: a possible role in cardiac inotropy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900172-4

Relations among sodium pump inhibition, Na-Ca and Na-H exchange activities, and Ca-H interaction in cultured chick heart cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900172-4

Ca2+ flux through promiscuous cardiac Na+ channels: slip-mode conductance.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900172-4

Carotid sinus baroreceptor sensitivity in experimental heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900172-4

Captopril versus digoxin in mild-moderate chronic heart failure: a crossover study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900172-4

Neurochemical evidence of cardiac sympathetic activation and increased central nervous system norepinephrine turnover in severe congestive heart failure.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900172-4

Effect of long-term digoxin therapy on autonomic function in patients with chronic heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900172-4

Value of digoxin in heart failure and sinus rhythm: new features of an old drug?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900172-4

Digoxin. A neurohormonal modulator in heart failure?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900172-4

Digoxin reduces cardiac sympathetic activity in severe congestive heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900172-4

Effects of Ouabain, Atropine, and Ouabain and Atropine, on A-V Nodal Conduction in Man

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900172-4

Effects of digoxin and enalapril on heart period variability and response to head-up tilt in normal subjects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900172-4

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900172-4

STUDIES ON DIGITALIS. X. EFFECTS OF OUABAIN ON FOREARM VASCULAR RESISTANCE AND VENOUS TONE IN NORMAL SUBJECTS AND IN PATIENTS IN HEART FAILURE

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900172-4

Acute effects of digoxin on total systemic vascular resistance in congestive heart failure due to dilated cardiomyopathy: a hemodynamic-hormonal study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900172-4

Hemodynamic effects of intravenous digoxin in patients with severe heart failure initially treated with diuretics and vasodilators

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900172-4

Variability of hemodynamic responses to acute digitalization in chronic cardiac failure due to cardiomyopathy and coronary artery disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900172-4

Comparative hemodynamic and neurohormonal effects of intravenous captopril and digoxin and their combinations in patients with severe heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900172-4

Acute hemodynamic effects of combined therapy with digoxin and nifedipine in patients with chronic heart failure.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900172-4

Combined therapy with digoxin and nitroprusside in heart failure complicating acute myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900172-4

Acute hemodynamic effects of digoxin alone or in combination with other vasoactive agents in patients with congestive heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900172-4

Digoxin for chronic heart failure: a review of the randomized controlled trials with special attention to the PROVED (Prospective Randomized Study of Ventricular Failure and the Efficacy of Digoxin) and RADIANCE (Randomized Assessment of Digoxin on

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900172-4

Sympathoinhibitory responses to digitalis glycosides in heart failure patients. Direct evidence from sympathetic neural recordings.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900172-4

Effect of digitalis on norepinephrine kinetics in congestive heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900172-4

Suppression of the renin-angiotensin system by intravenous digoxin in chronic congestive heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900172-4

Is digoxin really important in treatment of compensated heart failure? A placebo-controlled crossover study in patients with sinus rhythm

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900172-4

Digoxin Withdrawal After Cardiac Failure in Patients with Sinus Rhythm

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900172-4

Heart failure in outpatients: a randomized trial of digoxin versus placebo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900172-4

A controlled trial of digoxin in congestive heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900172-4

A comparison of oral milrinone, digoxin, and their combination in the treatment of patients with chronic heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900172-4

Randomized study assessing the effect of digoxin withdrawal in patients with mild to moderate chronic congestive heart failure: results of the PROVED trial. PROVED Investigative Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900172-4

Withdrawal of digoxin from patients with chronic heart failure treated with angiotensin-converting-enzyme inhibitors. RADIANCE Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900172-4

Patients with mild heart failure worsen during withdrawal from digoxin therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900172-4

The effect of digoxin on mortality and morbidity in patients with heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900172-4

Determinants of the renal clearance of digoxin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900172-4

Acute vasodilator therapy increases renal clearance of digoxin in patients with congestive heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900172-4

Clinical use of serum digoxin concentrations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900172-4

Effects of Increasing Maintenance Dose of Digoxin on Left Ventricular Function and Neurohormones in Patients With Chronic Heart Failure Treated With Diuretics and Angiotensin-Converting Enzyme Inhibitors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900172-4

Recognition and management of digitalis toxicity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900172-4

Treatment of 150 cases of life-threatening digitalis intoxication with digoxin-specific Fab antibody fragments. Final report of a multicenter study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900172-4

ACC/AHA Guidelines for the Evaluation and Management of Chronic Heart Failure in the Adult: Executive Summary A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Revise the 1995 Gu

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900172-4

Is the volume of distribution of digoxin reduced in patients with renal dysfunction? Determining digoxin pharmacokinetics by fluorescence polarization immunoassay

7 January 2021

series ordinal

58

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(02)00172-4

23 December 2023

Identifiers

1 reference

6 August 2017

1 reference